CSFZX | FIRCX | CSFZX / FIRCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 10 years | 18 years | - |
Gain YTD | 3.036 | 3.751 | 81% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.79B | 294M | 610% |
Annual Yield % from dividends | 2.91 | 0.09 | 3,095% |
Returns for 1 year | 7.75 | -0.62 | -1,252% |
Returns for 3 years | -5.89 | -27.18 | 22% |
Returns for 5 years | 1.87 | -25.51 | -7% |
Returns for 10 years | 35.75 | -9.20 | -389% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYWTX | 73.13 | 1.48 | +2.07% |
Rydex Emerging Markets 2X Strategy A | |||
NQGCX | 36.19 | -0.37 | -1.01% |
Nuveen Global Equity Income C | |||
ETCHX | 31.05 | -0.33 | -1.05% |
Eventide Healthcare & Life Sciences C | |||
GSVTX | 16.33 | -0.24 | -1.45% |
Goldman Sachs Large Cap Value Inv | |||
OLVCX | 19.51 | -0.42 | -2.11% |
JPMorgan Large Cap Value C |